SHORT AKAM ( AKAMAI )
July 30, 2008
Competition has increased in AKAM’s niche and likely to continue to increase. AKAM will continue to lose market share. After earnings release, the stock is
Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
Competition has increased in AKAM’s niche and likely to continue to increase. AKAM will continue to lose market share. After earnings release, the stock is
Yesterday ERTS reported lousy earnings and guidance below consensus. As a result, the stock has been hit hard trading as low as $42.50. A culture
Our proprietary money flow indicators have turned negative on oil. Sell all long positions.We will not yet short oil because slight geopolitical hiccup can make
Using our methodology, all of our short positions with the exception of VMW, AMLN and RHBBY should have been covered by now. If not fully
Our insight regarding production glitches hit the bull’s eye when the company reported earnings and the stock dropped as much as $15 in the after
Settlement with Nokia is a major change. Going forward, not only there will a be major reduction in ongoing legal costs, but more importantly a
WFR reports earnings after the close today. Our proprietary measurements show that the traders have been aggressive buyers this week and are positioned for bullish
Roche’s acquisition of DNA ( Genentech ) shows change of the company’s long practiced successful strategy by the new CEO. This indicates lack of confidence